Inovio (INO) Stock: Here’s What You Need To Know

Inovio Pharmaceuticals (NASDAQ:INO) On Monday, Inovio Pharmaceuticals closed the day down by 17% after the company announced that the FDA had placed its trial initiation on hold. This refers to the phase 3 clinical trial that was supposed to begin shortly treating women with cervical dysplasia or CIN 2/3 lesions. The vaccine to be used … Read more

Regulus Therapeutics (RGLS) Stock | Here’s What You Need To Know

Regulus Therapeutics (NASDAQ:RGLS) In after-hours trade on Monday June 27, 2016 shares of Regulus Therapeutics tanked as much as 60% after the company announced that the FDA had placed their Hepatitis C drug on a clinical hold. It is not a good thing that the company’s drug, RG-101 has been placed on a clinical hold. … Read more